PTEN and cancer: Zhang et al. [37] showed that the dependence of PTEN-deficient BT549 (breast) and PC3 (prostate) cancer cells on p110β was likely due to the selective binding by CRKL to p110β, facilitated by Src-phosphorylated p130Cas.